Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Acquisition

27 Jan 2015 07:01

RNS Number : 1870D
Kingspan Group PLC
27 January 2015
 

Kingspan Group plc

 

Acquisition

 

 

27 January 2015

 

Kingspan Group plc ("Kingspan") announces the acquisition of Joris Ide Group

 

Kingspan, the global leader in high performance insulation and building envelopes, is pleased to announce that it has entered into an agreement with Ergon Capital Partners II NV and Bremhove NV, to acquire 100% of the shares of Steel Partners NV, the holding company of the Joris Ide Group ("Joris Ide").

 

Joris Ide is a pan European manufacturer and supplier of insulated panels, profiles and related accessories, with leading market positions in France and the Benelux. It has 5 insulated panel manufacturing facilities in Belgium, Germany, Romania and Russia, and 11 regional manufacturing sites across Europe, which provide a uniquely complementary geographic footprint to Kingspan's existing European insulated panel business.

 

The consideration for the business will be circa EUR315m inclusive of debt, which will vary depending on the specific amount of working capital and debt on completion. The consideration will be satisfied on completion partly in cash and by the assumption of debt, with the balance of the consideration satisfied by the issue of three million shares in Kingspan Group plc to Bremhove NV, which is the holding company of the founder and major shareholder Mr Joris Ide.

 

In the 12 months to 31 December 2014, Joris Ide had unaudited revenues of EUR465m and EBITDA of EUR36m. Revenues and adjusted EBITDA to 31 December 2013 were EUR435m and EUR28m respectively. As at 31 December 2013, Joris Ide had gross assets of EUR316m, and on completion net assets excluding goodwill are expected to be EUR135m. The acquisition is expected to enhance earnings by circa 7 cent on a fully annualised basis.

 

The existing management team of Joris Ide will be retained in the business, and will continue to manage and develop the business distinct from the Kingspan brand. The acquisition is conditional on regulatory clearance, and is expected to complete towards the end of the first quarter of 2015.

 

Kingspan also announces that it has negotiated EUR127.5m private placement loan notes with weighted average maturities of 8 years. The weighted average coupon on the new notes is 1.92%. The proceeds will be primarily used to repay private placement loan notes which are due to mature in March 2015. Kingspan has also negotiated additional bilateral facilities of EUR190m. These facilities, together with cash and drawings from the previously undrawn Revolving Credit Facility, will be used to fund the Joris Ide and previously announced Vicwest acquisitions.

 

Gene Murtagh, Kingspan Chief Executive Officer, commented:

 

"The acquisition of Joris Ide Group represents a quantum leap forward in the execution of our strategy to fully globalise Kingspan. It takes us into a distinctly different tier in the market than typically occupied by the Kingspan branded products, and with its operations in Belgium, France, Germany, Romania and Russia significantly extends the reach of our Group."

 

Kingspan will hold an analysts' call at 8.30 GMT on 27 January 2015 to discuss the acquisition. A recording of this conference call will be available from 10.00 GMT on 27 January 2015 and full details of the number to call will be available on our website. For further information about the conference call please contact: julie.shankey@kingspan.com or +353 (0)42 969 8016.

 

 

 

For further information contact:

 

 

Kingspan

Gene Murtagh/Geoff Doherty

 

+353 42 9698000

Murray Consultants

Douglas Keatinge

+353 1 4980300

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEANFKASSSEFF
Date   Source Headline
18th Aug 20237:05 amRNSDelisting from the London Stock Exchange
18th Aug 20237:00 amRNSHalf-year Report
20th Jul 202311:37 amRNSResult of EGM
20th Jul 20239:56 amRNSHolding(s) in Company
18th Jul 20237:00 amRNSAcquisition
11th Jul 20237:00 amRNSTrading Update
3rd Jul 20232:40 pmRNSBlock listing Interim Review
3rd Jul 20232:34 pmRNSTotal Voting Rights
30th Jun 20234:54 pmRNSHolding(s) in Company
26th Jun 20232:00 pmRNSCircular and Notice of EGM
23rd Jun 20234:08 pmRNSHolding(s) in Company
14th Jun 20234:56 pmRNSHolding(s) in Company
14th Jun 20234:54 pmRNSHolding(s) in Company
1st Jun 20235:25 pmRNSTotal Voting Rights
2nd May 20235:09 pmRNSTotal Voting Rights
28th Apr 20234:07 pmRNSDirectorate Change
28th Apr 20234:00 pmRNSResult of AGM
28th Apr 20237:00 amRNSTrading Statement
3rd Apr 20234:40 pmRNSTotal Voting Rights
30th Mar 20239:00 amRNSDirector/PDMR Shareholding
21st Mar 20235:24 pmRNSDirector/PDMR Shareholding
20th Mar 20235:29 pmRNSHolding(s) in Company
20th Mar 20235:28 pmRNSHolding(s) in Company
16th Mar 20234:29 pmRNSHolding(s) in Company
16th Mar 20232:05 pmRNSNotice of AGM
1st Mar 20234:28 pmRNSTotal Voting Rights
1st Mar 20233:33 pmRNSHolding(s) in Company
1st Mar 202312:39 pmRNSDirector/PDMR Shareholding
28th Feb 20231:11 pmRNSDirector/PDMR Shareholding
24th Feb 20231:09 pmRNSHolding(s) in Company
23rd Feb 20234:57 pmRNSAnnual Financial Report
23rd Feb 20239:00 amRNSDirector/PDMR Shareholding
21st Feb 20235:34 pmRNSDirector/PDMR Shareholding
21st Feb 20235:28 pmRNSDirector/PDMR Shareholding
17th Feb 20237:30 amRNSDirectorate Change
17th Feb 20237:00 amRNSFinal Results
13th Feb 20236:02 pmRNSHolding(s) in Company
10th Feb 20233:00 pmRNSHolding(s) in Company
8th Feb 20234:35 pmRNSPrice Monitoring Extension
3rd Feb 20232:12 pmRNSHolding(s) in Company
2nd Feb 20234:27 pmRNSHolding(s) in Company
30th Jan 20232:48 pmRNSHolding(s) in Company
26th Jan 20234:40 pmRNSSecond Price Monitoring Extn
26th Jan 20234:35 pmRNSPrice Monitoring Extension
25th Jan 20234:05 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSHolding(s) in Company
17th Jan 20234:40 pmRNSHolding(s) in Company
3rd Jan 20239:05 amRNSBlock listing Interim Review
3rd Jan 20239:00 amRNSTotal Voting Rights
21st Dec 20224:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.